Published in Pediatr Res on March 01, 2009
Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol (2012) 2.50
Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol (2012) 1.44
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J (2013) 1.24
Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res (2011) 1.02
Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia. PLoS One (2010) 0.98
Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells. PLoS One (2010) 0.98
Receptor properties and features of cytokinin signaling. Acta Naturae (2012) 0.92
Modelling familial dysautonomia in human induced pluripotent stem cells. Philos Trans R Soc Lond B Biol Sci (2011) 0.92
Specific correction of a splice defect in brain by nutritional supplementation. Hum Mol Genet (2011) 0.82
Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatment. Eur J Hum Genet (2009) 0.80
Modeling neurological disorders by human induced pluripotent stem cells. J Biomed Biotechnol (2011) 0.79
Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia. PLoS Genet (2016) 0.78
Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease. Neurochem Int (2017) 0.75
The GPR54 gene as a regulator of puberty. N Engl J Med (2003) 9.54
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88
Prone vs supine positioning for breast cancer radiotherapy. JAMA (2012) 2.32
Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc Natl Acad Sci U S A (2004) 2.28
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell (2006) 2.02
Survival in familial dysautonomia: Impact of early intervention. J Pediatr (2002) 1.98
New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation (2005) 1.87
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol (2004) 1.73
Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) (2010) 1.68
Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet (2004) 1.58
Pacemakers in patients with familial dysautonomia--a review of experience with 20 patients. Clin Auton Res (2005) 1.54
Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res (2005) 1.52
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci (2006) 1.52
Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 1.51
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res (2012) 1.46
Anesthesia management of familial dysautonomia. Paediatr Anaesth (2006) 1.46
Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol Genet Metab (2006) 1.45
Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum Genet (2007) 1.44
Loss of mouse Ikbkap, a subunit of elongator, leads to transcriptional deficits and embryonic lethality that can be rescued by human IKBKAP. Mol Cell Biol (2008) 1.35
Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett (2002) 1.31
Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation (2003) 1.30
Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol (2006) 1.29
Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV. J Neuropathol Exp Neurol (2009) 1.26
Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet (2003) 1.26
Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol (2009) 1.25
Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol (2007) 1.23
Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol (2010) 1.20
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17
Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia. J Mol Med (Berl) (2007) 1.17
Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV. Biochem Biophys Res Commun (2004) 1.16
The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry (2005) 1.15
Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2005) 1.13
Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol (2012) 1.13
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Res Treat (2010) 1.12
CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One (2012) 1.12
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2012) 1.10
Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys (2012) 1.10
Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol (2002) 1.10
A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet (2003) 1.10
A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect. Genomics (2007) 1.08
Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry (2003) 1.07
Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol Dis (2010) 1.07
The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. Pflugers Arch (2009) 1.04
Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res (2011) 1.02
Usefulness of tilt-induced heart rate changes in the differential diagnosis of vasovagal syncope and chronic autonomic failure. Clin Auton Res (2009) 1.01
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res (2009) 1.01
Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99
Can loss of muscle spindle afferents explain the ataxic gait in Riley-Day syndrome? Brain (2011) 0.99
EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res (2013) 0.99
Atrioventricular valve development: new perspectives on an old theme. Differentiation (2012) 0.98
Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain (2004) 0.98
Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia. PLoS One (2010) 0.98
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97
Functional multimerization of mucolipin channel proteins. J Cell Physiol (2010) 0.97
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int (2004) 0.96
Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. Acad Med (2015) 0.96
Proactive approach to lymphedema risk reduction: a prospective study. Ann Surg Oncol (2014) 0.96
Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia. Am J Respir Crit Care Med (2002) 0.95
Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys (2012) 0.95
Familial dysautonomia: update and recent advances. Curr Probl Pediatr Adolesc Health Care (2006) 0.94
Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer (2010) 0.94
A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF). Br J Haematol (2013) 0.94
PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition. Mol Cancer Res (2013) 0.94
Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. Int J Radiat Oncol Biol Phys (2011) 0.94
Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia. Hum Mutat (2007) 0.93
Cyclic vomiting associated with excessive dopamine in Riley-day syndrome. J Clin Gastroenterol (2013) 0.93
Of splice and men: what does the distribution of IKAP mRNA in the rat tell us about the pathogenesis of familial dysautonomia? Brain Res (2003) 0.93
Effect of medication and psychotherapy on heart rate variability in panic disorder. Depress Anxiety (2009) 0.92
Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma. Anticancer Res (2010) 0.92
Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J Biol Chem (2010) 0.92
Identification of the first non-Jewish mutation in familial Dysautonomia. Am J Med Genet A (2003) 0.91
Molecular genetics of mitral valve prolapse. Curr Opin Cardiol (2007) 0.91
Extensive Riga-Fede disease of the lip and tongue. J Am Acad Dermatol (2002) 0.91
Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2013) 0.90
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer. Breast Cancer Res (2014) 0.90
Developmental basis for filamin-A-associated myxomatous mitral valve disease. Cardiovasc Res (2012) 0.90
Clinical neuro-ophthalmic findings in familial dysautonomia. J Neuroophthalmol (2012) 0.90
Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells. Hum Mutat (2012) 0.88
Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer. Am J Respir Cell Mol Biol (2002) 0.88